Position in NTRA
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$1,055,126
+$56,976 QoQ
Shares Held
3,887
-22.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#438
of 844 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Beacon Pointe Advisors, LLC holds $34,841,755 across 11 Diagnostics & Research names. NTRA ranks #6 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
37,709 | $18,905,784 | |
| 2 | MEDP |
Medpace Holdings, Inc.
|
8,911 | $4,719,176 | |
| 3 | DHR |
Danaher Corp /De/
|
20,988 | $3,997,794 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
4,300 | $2,263,692 | |
| 5 | MTD |
Mettler Toledo International Inc/
|
958 | $1,223,854 | |
| 6 | NTRA |
Natera, Inc.
This page
|
3,887 | $1,055,126 | |
| 7 | LH |
Labcorp Holdings Inc.
|
2,428 | $679,840 | |
| 8 | DGX |
Quest Diagnostics Inc
|
3,169 | $671,669 |
All Filings in NTRA
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,055,126 | 3,887 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $998,150 | 4,991 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $357,609 | 1,561 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $313,569 | 1,948 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $750,769 | 4,444 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $663,778 | 4,694 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $612,621 | 3,870 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $443,182 | 3,491 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $408,903 | 3,776 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $209,260 | 2,288 | Shares | Sole | 2024-05-14 | |
| No filing history on record for this holder in this stock. | ||||||